T racheal intubation is usually facilitated by adm m ministration of a muscle relaxant to supplem m ment drugs given for the induction of anesm m thesia. Over the past few years, several factors have led researchers to consider omitting neuromuscular blockm m ing agents for tracheal intubation. The driving forces were the apparent ability of propofol to blunt responses to tracheal stimulation 1 and the availability of the rapm m idly acting opioids, alfentanil and remifentanil. In addim m tion, the inappropriate use of neuromuscular blocking agents was thought to be involved in problems such as awareness, residual paralysis and allergy. Therefore, many studies focused on the possibility of performing tracheal intubation without the use of neuromuscular blocking agents. The challenge was to find the correct choice and dose of induction agent and opioid drug BACKGROUND AND OBJECTIVE: The combination of alfentanil-propofol or remifentanil-propofol provides adequate conditions for tracheal intubation without neuromuscular blocking drugs in most patients, but hypo--tension can occur during induction of anesthesia with propofol. We compared clinically acceptable intubating conditions and cardiovascular responses to induction and endotracheal intubation in patients receiving either alfentanil 40 µg/kg or remifentanil 2, 3 or 4 µg/kg, followed by thiopental 5 mg/kg.
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Mohammadreza Safavi, Azim Honarmand to produce adequate intubating conditions without cardiovascular side effects. The trachea can be sucm m cessfully intubated without neuromuscular blocking drugs after the alfentanilmpropofol induction sequence in most patients with normal anatomy. 2m4 In the study by JabbourmKhoury and colleagues, 5 excellent intubatm m ing conditions were found in 72% of American Society of Anesthesiologists (ASA) physical status I or II pam m tients receiving propofol 3 mg/kg in combination with alfentanil 20 µg/kg, but mean arterial blood pressure (MAP) in the alfentanil group decreased to 72±28 mm Hg (mean±standard deviation), which indicates that in 16% of ASA physical status I or II patients, MAP may reach 44 mm Hg (72 minus 28) or less.
Remifentanil is a new opioid agent with a speed of onset of effect similar to that of alfentanil, but with a shorter halfmlife as it undergoes rapid hydrolysis by nonmspecific blood and tissue esterases. 6 Remifentanil as part of an induction regimen effectively attenuates the hemodynamic response to laryngoscopy and tram m cheal intubation. 7m8 Although the trachea can be relim m ably intubated without a neuromuscular block in pam m tients who have received remifentanil followed by prom m pofol, 9 hypotension during the induction of anesthesia with propofol can occur.
10, 11 Alexander et al 12 reported MAP values less than 45 mm Hg in 27% of patients rem m ceiving 4 or 5 µg/kg remifentanil in combination with propofol. With a lower dose of remifentanil (3 µg/kg) intubating conditions were poor in 30% of cases. In other words, when neuromuscular blocking agents are not used, there is a high risk of either poor intubatm m ing conditions or hypotension. The decreases in MAP and heart rate values may be well tolerated in healthy, wellmhydrated patients, but this technique cannot be recommended for sick, hypovolemic or debilitated pam m tients, the elderly, or those with clinically significant cardiovascular or cerebrovascular disease. The results of the Erhan et al 13 study indicated that propofol might be a better hypnotic agent for tracheal intubam m tion, but at the risk of hypotension when for omitting neuromuscular blocking agents. Since 1948, thiopental alone has been used to facilitate endotracheal intubam m tion.
14 Furthermore, thiopental, rather than propofol, may provide more favorable intubating conditions. 15 Durmus and colleagues 16 showed that remifentanil 4 µg/kg administered before thiopental 5 mg/kg providm m ed excellent or satisfactory intubation conditions with acceptable hemodynamic changes. With respect to the intubating conditions and cardiovascular responses there was no previous information on equipotency bem m tween alfentanil and remifentanil. Experience obtained from pilot studies gave us reason to choose three dism m tinct doses of remifentanil to be compared with alfenm m tanil before induction of anesthesia with thiopental, the dose of which was chosen on the basis of previous results. A larger dose of alfentanil might have provided as favorable conditions for intubation as remifentanil 4 mg/kg. However, data from prospective studies comparing intubation conditions after remifentanilm thiopental with alfentanilmthiopental combination are lacking so we designed this randomized, doublemblind study to compare clinically acceptable intubating conm m ditions and cardiovascular responses to induction and endotracheal intubation in premedicated patients rem m ceiving either alfentanil 40 µg/kg or remifentanil 2, 3 or 4 µg/kg, followed by thiopental 5 mg/kg.
PATIENTS AND METHODS
After obtaining approval from our ethics committee and written informed consent from the patients, we enrolled 80 ASA physical status ImII patients aged 18 to 60 years scheduled for elective surgery into this randomized, doublemblind study. Exclusion criteria included a hism m tory of drug or alcohol abuse, gastroesophageal reflux or hiatus hernia, cardiovascular disease, reactive airway disease, a body mass index of 30 or more, administram m tion of sedative or narcotic drugs in the previous 24 hours, renal or hepatic impairment, and predicted diffim m culty in intubation or airway maintenance. All patients were premedicated with midazolam 0.03 mg/kg IV approximately 5 minutes before the induction of anesm m thesia. All patients were prehydrated with physiological saline (0.9%) 7 mL/kg before induction of anesthesia. Patients were randomly assigned to receive remifentm m anil 2, 3, or 4 µg/kg (groups R2, R3, R4, respectively, n=20 per group) or alfentanil 40 µg/kg (group A40, n=20) by means of individually prepared envelopes. Remifentanil and alfentanil syringes were prepared by an independent anesthesiologist in a total volume of 10 mL with 0.9% saline. Therefore, all anesthesia personnel were blinded to the dose of remifentanil. Baseline heart rates (HR), systolic arterial blood pressure (SAP), diam m stolic arterial blood pressure (DAP), and mean arterial pressures (MAP) were recorded. After preoxygenation for 2 minutes, the study drug was then injected over 90 seconds by an assistant behind a drape so that the anm m esthesiologist performing the intubation was blinded to drug doses. Sixty seconds later, thiopental 5 mg/kg was given over 40 seconds. When the patient became unconm m scious, judged by the loss of the response to command and the loss of the eyelash reflex, manual ventilation of the lungs by a facemask was started. Fortymfive seconds after thiopental, the patient' s postinduction vital signs were recorded. Ninety seconds after the thiopental administration, laryngoscopy and intubation were atm m tempted by the same experienced anesthesiologist using a Macintosh 3 laryngoscope blade and a 7.0m or 8.0mmm endotracheal tube (for women and men, respectively). The endotracheal tube cuff was inflated slowly. The anesthesiologist performing the intubation assessed and scored the condition of each patient at laryngosm m copy and tracheal intubation using these criteria 7 : (a) excellent defined by flaccid relaxation of jaw muscles, mouth wide open, good cord visualization, cord well separatedmabducted, and no bucking at intubation; (b) satisfactory defined by mouth easily opened, jaw musm m cles well relaxed, good cord visualization, slight cord movement when touched but abducted, and minimal bucking at intubation; (c) fair defined by conditions less favorable, jaw muscles not well relaxed, cord visualizam m tion fair but allowing intubation, and bucking on intum m bation; (d) unsatisfactory defined by poor relaxation of the jaw and resistance to opening the mouth, poor cord visualization or none, cord abducted if viewed, superior pharyngeal constrictor muscle activity, and patient unm m able to be intubated or, if intubated, marked bucking and body movement. Patients who could not be intum m bated on the first attempt were given succinylcholine 1 mg/kg intravenously, and intubation was completed. Adverse events such as laryngospasm, bronchospasm or chest wall rigidity, indicated by difficulty in ventilating the lungs, and the administration of further drugs were also recorded. Monitors included an automated artem m rial pressure cuff, electrocardiogram, peripheral pulse oximeter and capnometer. Control values for arterial pressure, heart rate and peripheral oxygen saturation (SpO 2 ) were obtained before induction. Then the meam m surements were performed 45 seconds after the bolus dose of thiopental was given (postinduction) and 1, 3, 5, 10, and 15 minutes after the intubation. Hypotension (MAP <25% from baseline for 60 seconds) was treated with ephedrine 5m10 mg IV and bradycardia (HR <50 bpm for 60 seconds if hypotension occurred) was treatm m ed with atropine 20 µg/kg IV. Anaesthesia was mainm m tained with 0.5m1% isoflurane and 66% nitrous oxide in oxygen, and the lungs were ventilated to normocapnia.
Based on a pilot study, a sample size of 20 was rem m quired for an 80% chance of demonstrating a signifim m 
RESULTS
Demographic variables of patients and duration of operation were comparable among the four groups (Table 1) . Tracheal intubation conditions in the difm m ferent groups are shown in Figure 1 . There was a sigm m nificant improvement in intubation conditions between All hemodynamic variables decreased to statistically significant levels after the induction of anesthesia compared with the baseline levels within groups. Data are presented as mean±SD. Statistically significant differences * between group r2 and r3, † between group r2 and r4, ‡ between group r2 and A40, § between group r3 and r4, # between group r3 and A40.
groups R2 and R3, R2 and R4, and between R3 and R4 (P<.05). Intubation conditions were not significantly different between group R4 and A40 (P>.05). Among all patients, 3 from group R2, 1 from group R3, and 1 from group A40 could not be intubated (P>.05), but afm m ter the administration of 1.5 mg/kg of succinylcholine, intubation was easily performed. During induction of general anesthesia, no patient manifested clinically significant opioidminduced rigidm m ity (P>.05). Coughing was observed in 3, 2, 1, and 1 patient in group R2, R3, R4, and A40, respectively (P>.05). Movement at intubation was observed in 8 patients from group R2, 2 patients from group R3, 1 patient from group R4, and 1 patient from group A40 (P<.01).
The baseline values in HR, SAP, DAP, and MAP were comparable between the groups. Compared with the baseline levels, the decrease in HR, SAP, DAP, and MAP were significant in all groups after anesm m thetic induction and endotracheal intubation (P<.05). Immediately after intubation, heart rate did not change in all groups when compared with the postinduction values. Immediately after intubation, SAP increased significantly only in group R2 (P<.05), whereas DAP and MAP increased significantly in all groups (P<.05) when compared with the postinduction values. The difm m ferences between the groups were not significant. All hemodynamic variables and differences among groups and within groups are shown in Table 2 . There was no significant difference between group R4 and A40 with respect to HR, SAP, DAP, and MAP in all times of measurement. MAP decreased 18.7% in group R4 after induction of anesthesia compared with a 16.4% decrease in group A40 (difference not statistically significant). Bradycardia, which was treated by atropine, was obm m served in 2 patients from group R4 and 1 patient from group A40 (P>.05). Hypotension was observed in 1, 2, and 1 patients in groups R3, R4, and A40, respectively (P>.05), which was treated by ephedrine. Peripheral oxygen saturation remained at preinduction values (97m 98%) in all groups throughout the investigation.
DISCUSSION
The results of this study suggest that thiopental 5 mg/ kg administered with remifentanil 4 µg/kg or alfentanil 40 µg/kg provide excellent or satisfactory intubation conditions with acceptable hemodynamic responses in healthy, premedicated patients with favorable airway anatomy. Remifentanil 4 µg/kg or alfentanil 40 µg/kg offered a significant improvement in overall conditions for intubation compared with remifentanil 2 or 3 µg/kg. Three patients (15%) could not be intubated with remim m fentanil 2 µg/kg, but increasing the dose to 3 or 4 µg/kg or administrating alfentanil 40 µg/kg led to satisfactory or excellent intubating conditions in 95%, 100%, and 95% of patients, respectively. Durmus and colleagues 16 compared different doses of remifentanil in combination with thiopental 5 mg/kg and reported that remifentanil 4 µg/kg provided satism m factory intubating conditions more reliably than remim m fentanil 2m3 µg/kg. Kleomola and colleagues, 9 in a study that included a standard comparator group receiving alm m fentanil, reported that administration of remifentanil 4 µg/kg in combination with propofol 2.5 mg/kg offered significant improvements in overall conditions comm m pared with alfentanil 30 µg/kg. They found that tracheal intubation was judged impossible in 20%, 25% and 5% of patients receiving alfentanil 30 µg/kg, remifentanil 3 µg/kg or remifentanil 4 µg/kg, respectively. In contrast, in our study, tracheal intubation was possible in 95% and 100% patients given alfentanil 40 µg/kg or remifenm m tanil 4 µg/kg before thiopental 5 mg/kg, in which the higher dose suggested by Scheller and colleagues 4 was used. In Kleomola et al, excellent intubating conditions were significantly more frequent in patients receiving remifentanil 4 µg/kg compared with alfentanil 30µg/ kg (55% versus 20%). In our study, excellent intubatm m ing conditions were seen in 85% of patients receiving remifentanil 4 µg/kg and 80% of patients receiving alm m fentanil 40 µg/kg. This shows that induction of anesm m thesia with 40 µg/kg alfentanil before the usual dosage of thiopental probably provides more satisfactory intum m bation conditions compared with 40 µg/kg alfentanil before propofol. In a study by JabbourmKhoury et al, 17 72% of patients receiving alfentanil 20 µg/kg before propofol 3 mg/kg had excellent intubating conditions. MAP decreased to a low level of 44 mm Hg or less in some patients. In our results, MAP decreased maxim m mally to 75.8±3.7 and 76.8±4.0 in group R4 and A40, respectively. Hypotension is common with large doses of opioids. In a study by Alexander and colleagues, 12 27% of patients receiving 4 or 5 µg/kg remifentanil bem m fore propofol had a MAP less than 45 mm Hg. Thirty percent of patients receiving a lower dosage of remifenm m tanil (3 µg/kg) had poor intubating conditions. In our study, there was no patient with a MAP <45 mm Hg. Increasing the dose of remifentanil provides acceptable intubation conditions for premedicated patients, but rem m sults in an 18% decrease in MAP.
In our study, which included use of thiopental inm m stead of propofol as induction agent, bradycardia or hypotension was observed in two patients from group R4 and one patient from group A40. The bradycardia and hypotension were treated by atropine or ephedrine, respectively, while atropine was not used before injecm m tion of study drugs. All these studies were conducted in healthy patients scheduled for elective surgery. Propofol is superior to barbiturates in decreasing muscle tone and abolishing laryngeal responses to tracheal intubation or to laryngeal mask insertion. 18, 19 The possible developm m ment of severe hypotension is a limiting factor for usm m ing propofol, 10,11 whereas thiopental may provide more favorable intubation conditions according to a study by Hovorka et al, 15 while causing less hemodynamic dem m crease. In the present study, the induction of anesthesia with thiopental 5 mg/kg and remifentanil 2m4 µg/kg or alfentanil 40 µg/kg resulted in significant decreases in HR, SAP, DAP, and MAP values. Increasing the dose of remifentanil provided acceptable intubation condim m tions for premedicated patients, but resulted in a 14.3%, 22.4%, and 18.7% decrease in SAP, DAP, and MAP, respectively. These hemodynamic changes can be seen with any inhaled or IV induction regimen. Alfentanil 40 µg/kg, compared with remifentanil 4 µg/kg, caused a 12.7%, 18.7%, 16.4% decrease in SAP, DAP, and MAP.
In addition to acceptable intubation conditions, the usual increase in cardiovascular responses after tracheal intubation was not observed in any group in this study. With regard to cardiovascular parameters, there was dism m similarity between the changes caused by the different drug combinations both after induction and intubation. In two previous studies, 2 the mean reductions after anm m esthetic induction with propofol combined with either alfentanil or remifentanil was 19% to 23% in systolic and 23% to 29% in diastolic arterial pressure. In conm m trast, in our study, the mean reductions after anesthetic induction with thiopental combined with either remim m fentanil 4 µg/kg or alfentanil 40 µg/kg was 13.6% and 12.5% in SAP, and 19.6% and 18.7% in DAP, respecm m tively. The reduction in MAP was 17% in group R4 and 15.9% in group A40. The decrease in arterial pressure following remifentanilmpropofol or alfentanilmpropofol combination might not be well tolerated in less healthy patients such as the elderly, compromised patients, or in patients with clinically significant cardiovascular or cerebrovascular disease. If we want to achieve adequate intubating conditions with less hemodynamic change, thiopental seems superior to propofol.
Generally, muscle rigidity may be associated with rapid infusions of large doses of potent opioids. 20 After remifentanil, such muscle rigidity was demonstrated in 11% to 32% of patients with target concentrations escam m lating from 2.0 to 16.0 ng/mL. 21 However, none of our midazolam premedicated patients exhibited signs of opioidminduced muscular rigidity such as stiff chest. The lungs of all patients could be easily ventilated via mask.
Our results are in agreement with those obtained previm m ously in which drug combination and dosage were simim m lar to ours. 4 After alfentanil, no muscular rigidity was observed, which is similar to the Scheller et al study. 4 The absence of signs indicating opioidminduced muscum m lar rigidity in our patients might be due to the rather moderate injection rate of the opioids. Nevertheless, it has been suggested that the incidence and severity are dependent not only on the dose but also the rate of administration. 20, 22 Further, there is evidence that prem m treatment with a benzodiazepine is effective in preventm m ing opioidminduced muscle rigidity. 23 In the present study, we did not use atropine before injection of study drugs. HR was consistently reduced in the period after induction with alfentanil and the varying doses of remifentanil. This decrease necessim m tated treatment only in 2 patients from group R4 and 1 patient from group A40. Note that the routine use of atropine to mask the side effects of highmdose remifentm m anil also has its own side effects because of the blockade of muscarinic cholinergic receptors in the periphery and in the central nervous system. Peripheral effects, e.g. a dry mouth, may be irritating, but atropine has a mild antisialagogue effect compared with glycopyttolate and scopolamine. 24 Central nervous system side effects have been seen with relatively large doses of atropine, e.g. 1m2 mg. 24 Our results confirm better control of hemodynamic changes following induction with thiopental compared with propofol. It is important to avoid the side effects of anesthesia (e.g., postoperative myalgias, nausea and vomiting) that may delay the discharge or return to routine activities of living of the daymsurgery patient. It is also advantageous in cases where tracheal intubation is necessary, but neuromuscular block is not required, to facilitate surgical access. Avoiding muscle relaxants when they are not required for the planned procedure may help to achieve this objective. For example, the clinician might avoid succinylcholine and its potential to cause associated myalgias, 25 as well as its less comm m mon, more serious complications (e.g., masseter spasm, malignant hyperthermia, cardiac rhythm disturbances). When nondepolarizing muscle relaxants are not used, the clinician may also avoid the complications of their antagonism, including the potential to increase postm m operative nausea and vomiting. 26 The use and misuse of muscle relaxants is often thought to contribute to awareness. The administration of muscle relaxants durm m ing balanced anaesthesia is often routine, albeit often unnecessary, and it removes important motor signs of awareness. Limiting the use of muscle relaxants to apm m propriate indications and not using them as substitutes for anesthesia, or to prevent movement in all patients, should help one to prevent awareness. 27 Grant and colm m leagues 28 suggested that this technique could also be advantageous in the event of a prolonged difficult intum m bation that was predicted or unexpected, since it could allow assessment of the airway by laryngoscopy. The decision whether or not to awaken the patient or prom m ceed could then be made. It should also be noted that tracheal intubation without neuromuscular block can be hazardous in some situations. If laryngoscopy and intubation are attempted under inadequate conditions (e.g., poor jaw relaxation, closed vocal cords), trauma to the airway or inadequate ventilation can result. In addition, remifentanil can result in severe bradycardia, muscle rigidity, apnea, and an increased incidence of postoperative nausea and vomiting. 29, 30 We conclude that the administration of remifentanil 4 µg/kg or alfenm m tanil 40 µg/kg before thiopental 5 mg/kg provided good to excellent conditions for endotracheal intubation with acceptable hemodynamic changes. The combination tom m tally prevented the cardiovascular intubation response. The technique may be appropriate when neuromuscular blockade is undesirable or not required for the planned surgical procedure.
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